can be read here
Human Medications, Human Drugs, Animal Medications, Animal Drugs, Pharmacy law, Pharmaceutical law, Compounding law, Sterile and Non Sterile Compounding 797 Compliance, Veterinary law, Veterinary Compounding Law; Health Care; Awareness of all Types of Compounding Issues; Pharmacy Benefit Managers (PBMs), Outsourcing Facilities Food and Drug Administration and Compliance Issues
Showing posts with label POSH CHEMICALS PRIVATE LTD RECEIVES FDA WARNING LETTER. Show all posts
Showing posts with label POSH CHEMICALS PRIVATE LTD RECEIVES FDA WARNING LETTER. Show all posts
Monday, September 16, 2013
Wednesday, September 4, 2013
Barry A. Friedman Blog FAILURE TO PROTECT COMPUTERIZED DATA – A REMINDER OF SANDOZ AND CEPHAZONE PHARMA’S FDA WARNING LETTER ISSUES Posted on September 3, 2013
POSH CHEMICALS PRIVATE LTD RECEIVES FDA WARNING LETTER (8/2/13) During the timeframe of March 3-8, 2013 the FDA inspected Posh Chemicals Private Ltd, Hyderabad, India. A total of three Observations were received. Of particular note is Observation 1 which is … Continue reading →
Subscribe to:
Posts (Atom)